MEDNA launching Quantitative Binding Antibody Test for SARS-CoV-22020-06-16
Based in Irving Texas, MEDNA launched a Quantitative Binding Antibody Test for SARS-2CoV-2. This test detects the presence or absence of antibodies to SARS-CoV-2, the virus that causes COVID-19. MEDNA's quantitative binding test detects IgG antibody content in blood samples. It provides a quantitative readout instead of positive or negative result reporting. This test is an important tool in the fight against COVID-19 in the coming months as people wish to know if they've been exposed.
• Antigen is the full-length trimeric spike protein of SARS-CoV-2 virus
• Quantitative readout instead of positive or negative reading
• Works with venous blood collection as well as finger prick
Visit https://dx.medna.us/ for more information.